Robyn J. Levy

3.1k citations

37 papers · 1.6k indexed · h-index 19

Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 29
Hematology top 2%
- Hemophilia Treatment and Research 9
Rheumatology top 2%
- Urticaria and Related Conditions 8
Nutrition and Dietetics top 2%
- Vitamin K Research Studies 7
Pathology and Forensic Medicine top 5%
- Autoimmune Bullous Skin Diseases 9
Immunology
- Mast cells and histamine 9
- Immunodeficiency and Autoimmune Disorders 4
Molecular Biology
- Enzyme function and inhibition 3

Co-authors: H. Henry Li Timothy Craig Marco Cicardi William E. Pullman Patrick T. Horn Marilyn Campion Richard L. Wasserman Dumitru Moldovan
Cited by: Genetics Hematology Rheumatology
Partner nations: United States Romania Israel

In The Last Decade

Robyn J. Levy

37 papers receiving 1.6k citations

Peers

Countries citing papers authored by Robyn J. Levy

Since Specialization

Citations

This map shows the geographic impact of Robyn J. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn J. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn J. Levy more than expected).

Fields of papers citing papers by Robyn J. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn J. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn J. Levy. The network helps show where Robyn J. Levy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robyn J. Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robyn J. Levy Line = papers co-authored together Robyn J. Levy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease Richard L. Wasserman,William R. Lumry,James B. Harris,Robyn J. Levy,Mark R. Stein,Lisa R. Forbes,Charlotte Cunningham‐Rundles,Isaac Melamed,Ai Kobayashi,Wei Du,Roger H. Kobayashi	2016	23
2	Recombinant Human-C1 Inhibitor Is Effective and Safe for Repeat Hereditary Angioedema Attacks H. Henry Li,Dumitru Moldovan,Jonathan A. Bernstein,Avner Reshef,Grzegorz Porębski,Marcin Stobiecki,James Baker,Robyn J. Levy,Anurag Relan,Marc A. Riedl	2015	30
3	Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial Marc A. Riedl,Jonathan A. Bernstein,Henry Li,Avner Reshef,William R. Lumry,Dumitru Moldovan,Henriette Farkas,Robyn J. Levy,James Baker,Yun Hardiman,Mark C. Totoritis,Anurag Relan,Marco Cicardi	2014	60
4	Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study Marc A. Riedl,Robyn J. Levy,Daniel Suez,Richard F. Lockey,James Baker,Anurag Relan,Bruce L. Zuraw	2013	42
5	Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients Andy Kusuma,Anurag Relan,André C. Knulst,Dumitru Moldovan,Bruce L. Zuraw,Marco Cicardi,Robyn J. Levy,Jan H. Nuijens,C. Erik Hack	2012	19
6	Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks Michael J. Prematta,Againdra K. Bewtra,Robyn J. Levy,Richard L. Wasserman,Kraig W. Jacobson,Thomas Machnig,Timothy Craig	2012	24
7	Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Subcutaneous (SC) Cinryze® (C1 inhibitor (C1 INH) with Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Hereditary Angioedema (HAE) Jennifer Schranz,Robyn J. Levy,William R. Lumry,Michael Manning,Joshua Jacobs,Samuel S. Dychter,Michael J. LaBarre,A. Phillips,Steven P Gelone,Colin Broom	2012	4
8	Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial William R. Lumry,H. Henry Li,Robyn J. Levy,Paul C. Potter,Henriette Farkas,Dumitru Moldovan,Marc A. Riedl,Hongbin Li,Timothy Craig,Bradley J. Bloom,Avner Reshef	2011	178
9	Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies Albert L. Sheffer,Marilyn Campion,Robyn J. Levy,H. Henry Li,Patrick T. Horn,William E. Pullman	2011	49
10	Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial Marc A. Riedl,David Hurewitz,Robyn J. Levy,Paula J. Busse,David Fitts,Ira N. Kalfus	2011	24
11	C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study Timothy Craig,Againdra K. Bewtra,Sami L. Bahna,David Hurewitz,Lynda C. Schneider,Robyn J. Levy,James N. Moy,J. Offenberger,Kraig W. Jacobson,W.H. Yang,F. Eidelman,G. Janss,Flint Packer,Mikhail Rojavin,Thomas Machnig,Heinz-Otto Keinecke,Richard L. Wasserman	2011	104
12	Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks William R. Lumry,H.H. Li,Robyn J. Levy,Paul C. Potter,Henriette Farkas,Avner Reshef,Dumitru Moldovan,Marc A. Riedl,H. Li,Bradley J. Bloom	2011	10
13	Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema Marco Cicardi,Robyn J. Levy,Donald McNeil,H. Henry Li,Albert L. Sheffer,Marilyn Campion,Patrick T. Horn,William E. Pullman	2010	234
14	EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema Robyn J. Levy,William R. Lumry,Donald McNeil,H. Henry Li,Marilyn Campion,Patrick T. Horn,William E. Pullman	2010	116
15	Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema Timothy Craig,Richard L. Wasserman,Robyn J. Levy,Againdra K. Bewtra,Lynda C. Schneider,Flint Packer,William H. Yang,H. Keinecke,Peter Kießling	2010	37
16	Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks Richard L. Wasserman,Robyn J. Levy,Againdra K. Bewtra,David Hurewitz,Timothy Craig,Peter Kießling,Heinz-Otto Keinecke,Jonathan A. Bernstein	2010	13
17	Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks Jonathan A. Bernstein,Bruce Ritchie,Robyn J. Levy,Richard L. Wasserman,Againdra K. Bewtra,David Hurewitz,Krystyna Obtułowicz,Avner Reshef,Dumitru Moldovan,Todor Shirov,Vesna Grivcheva‐Panovska,Peter Kießling,F. Schindel,Timothy Craig	2010	24
18	Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema Bruce L. Zuraw,Marco Cicardi,Robyn J. Levy,Jan H. Nuijens,Anurag Relan,Sonja Visscher,Gerald M. Haase,Leonard Kaufman,C. Erik Hack	2010	174
19	Safety and Efficacy in Children with Persistent Asthma Treated with Formoterol 10 µg BID Delivered via Certihaler ^™ : A Novel Multidose Dry-Powder Inhaler Robyn J. Levy,Jacob L. Pinnas,Henry Milgrom,Jonathan A. Smith,Ümit Yegen	2005	10
20	Treatment of Status Epilepticus With Lorazepam Robyn J. Levy,Ronald L Krall	1984	39

About Robyn J. Levy

Robyn J. Levy is a scholar working on Genetics, Hematology and Immunology, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers), Mast cells and histamine (9 papers), Autoimmune Bullous Skin Diseases (9 papers), Hemophilia Treatment and Research (9 papers), Urticaria and Related Conditions (8 papers), Vitamin K Research Studies (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Enzyme function and inhibition (3 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (521 citations) and Rheumatology (580 citations). Robyn J. Levy has collaborated with scholars based in United States, Romania and Israel. Frequent co-authors include H. Henry Li, Timothy Craig, Marco Cicardi, William E. Pullman, Patrick T. Horn, Marilyn Campion, Richard L. Wasserman, Dumitru Moldovan, Donald McNeil and Avner Reshef.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact